, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like

ที่บชง Page 1 of 4 Ref. Bor Chor Ngor 0048/2020 26 February 2020 Subject: Management Discussion and Analysis of Operating Results for Fiscal Year 2019 To President The Stock Exchange of Thailand

(Translation) Ref. No. 1808/036EN August 10, 2018 Subject: Operating Result Clarification for Q2/2018 (Ending June 30, 2018) To: Director and Manager of the Stock Exchange of Thailand Ubis (Asia

Ref. MD 115/2017 August 25, 2017 Re: Clarification on the Financial Performance of the Company and its subsidiaries as of Year 2015 Attn: President The Stock Exchange of Thailand We, K. C. Property

-TRANSLATION- 15 May 2019 Subject : Management Discussion and Analysis for Q1/2019 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in

-TRANSLATION- 15 May 2020 Subject : Management Discussion and Analysis for Q1/2020 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in

: The President The Stock Exchange of Thailand Takuni Group Public Company Limited (“The Company”) and its subsidiaries (“The Group”) would like to clarify the change in operating result for the period

Acc. 003/2019 May 13, 2019 To: The President The Stock Exchange of Thailand Subject: Management discussion and analysis (MD&A) for Quarter 1/2019 Dear Sir, S. Khonkaen Foods Public Company Limited or

Exchange of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2020, held on 19th February 2020, approved the audited financial statements, including the

Re: Rules for entering into a substantial transaction classified as an acquisition or disposal of assets, dated August 31, 2008 (as amended) and Notification of Stock Exchange of Thailand Board Re